Batsvik, et al
4
|
2015 |
Hauckland University Hospital, Bergen, Norway (1982‐1985) |
24 y |
<1000 g or < 28 wk |
43 in 51 eligible study group; 43 in 46 eligible controls |
SF‐36 |
Self‐report |
Baumann, et al
14
|
2016 |
Bavarian Longitudinal Study (BLS), Germany (1985‐1986) |
26 y |
<1500 g or < 32 wk |
201 in 411 eligible study group; 190 in 308 eligible controls |
HUI‐3 |
Self‐report and parent report |
Bjerager, et al
15
|
1995 |
State University Hospital Copenhagen, Denmark (1971‐1974) |
18‐20 y |
<1500 g |
85 in 107 eligible study group; 85 in 110 eligible controls |
Customised questionnaire
a
|
Telephone interviews |
Björqvist, et al
17
|
2017 |
Helsinki Study of VLBW adults, Finland (1971‐1974) |
18‐27 y |
<1500 g |
164 in 255 eligible study group; 172 in 314 eligible controls |
15‐D |
Self‐report |
Cooke
11
|
2004 |
Liverpool Maternity hospital, in UK (1980‐1983) |
19‐22 y |
<1500 g or < 31 wk |
79 in 138 eligible study group; 71 in 163 eligible controls |
SF‐36 |
Self‐report |
Darlow, et al
3
|
2013 |
1986 cohort, (all VLBW) in New Zealand |
22‐23 y |
<1500 g |
230 in 251 eligible study group; 69 controls |
SF‐36 |
Face‐to‐face interview |
Dinesen & Greisen
16
|
2001 |
Rigshospitalet Copenhagen, in Denmark (1980‐1982) |
18 y |
<1500 g |
79 in 114 VLBW study group seen at 2yrs; 69 in 92 controls seen at 4 yrs |
Customised questionnaire
a
|
Telephone interview |
Gaddlin, et al
12
|
2009 |
South‐eastern Sweden (1987‐1988) |
20 y |
<1500 g |
77 in 86 surviving study group; 69 in 86 surviving controls |
SF‐36 |
Self‐report (2 telephone interviews; 2 other participants had help due to disability) |
Hack, et al
18
|
2007 |
Rainbow Babies and Children's hospital, Cleveland, Ohio, USA |
20 y |
<1500 g |
241 in 312 surviving study group; 232 in 363 surviving controls |
Chip‐AE |
Self‐report (5% read aloud due to reading difficulties) |
Hallin & Stjernqvist
19
|
2011 |
Southern Sweden (1985‐1986) |
18 y |
<29 wk |
52 in 59 eligible study group and 54 in 61 eligible controls |
Visual analogue scale ranging 0‐100
b
|
Self‐report |
Husby, et al
6
|
2016 |
St. Olavs Hospital Trondheim, in Norway (1986‐1988) |
23 y |
<1500 g |
35 in 54 invited study group; 37 in 48 invited controls |
SF‐36 |
Self‐report |
Lund, et al
5
|
2012 |
St. Olavs Hospital Trondheim, Norway (1986‐1988) |
20 y |
<1500 g |
43 in 59 invited study group; 74 in 102 invited controls |
SF‐36 |
Self‐report |
Natalucci, et al
10
|
2013 |
(all ELBW) in Switzerland (1983‐1985) |
22‐26 years |
<1000g |
55 in 65 traced study group, no controls; community norms |
SF‐36 |
self‐report |
Poole, et al
8
|
2017 |
McMaster cohort, Central‐west Ontario, Canada (1977‐1982) |
22‐26 y |
<1000 g |
70 in 179 surviving study group; 83 in 145 recruited at 8yrs controls |
SF‐36 |
Self‐report |
Roberts, et al
13
|
2013 |
Victoria, Australia (1991‐1992) |
18 y |
<1000 g or < 28 wk |
186 (HUI3)/183 (SF‐36) in 298 surviving study group; 138 (HUI3)/144 (SF‐36) in 262 matched controls |
SF‐36 & HUI‐3 |
Self‐report |
Saigal, et al
7
|
2006 |
McMaster cohort, Central‐west Ontario, Canada (1977‐1982) |
23 y |
<1000 g |
143 in 179 surviving study group; 130 in 145 recruited at 8yrs controls |
HUI‐2; plus hypothetical states |
Interview self‐report (parents proxy for impaired participants) |
Saigal, et al
9
|
2016 |
McMaster cohort, Central‐west Ontario, Canada (1977‐1982) |
22‐26 y AND 29‐36 y |
<1000 g |
141 (22‐26 y) and 94 (29‐36 y) in 179 surviving study group; 133 & 83 in 145 recruited at 8yrs controls |
HUI‐3 |
interview |
Vederhus, et al
20
|
2015 |
Haukeland University Hospital, Bergen, Norway (1991‐1992) |
18 y |
<1000 g or < 28 wk |
31 in 35 eligible study group; 29 in 35 eligible controls |
Child Health Questionnaire (CHQ) |
Self‐report and parent report |